World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
41434
World Ranking
8513
National Ranking
100

Overview

Allan Vaag is affiliated with the Steno Diabetes Center in Denmark and has a substantial research output primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work incorporates subfields such as Pediatrics, Perinatology and Child Health, Endocrinology, Diabetes and Metabolism, Physiology, Obstetrics and Gynecology, and Molecular Biology.

Vaag's research topics cover various aspects of health and metabolism including Birth, Development, and Health, Gestational Diabetes Research and Management, Diet and metabolism studies, Diabetes Management and Research, Epigenetics and DNA Methylation, Pregnancy and preeclampsia studies, and Adipose Tissue and Metabolism.

The scientist has contributed extensively to multiple publication venues, with the most frequent being Diabetes, Diabetologia, Diabetes Care, BMJ Open Diabetes Research & Care, and Nature Communications.

Recent published papers include:

  • Lactation Duration and Long-term Risk for Incident Type 2 Diabetes in Women With a History of Gestational Diabetes Mellitus, 2020, Diabetes Care
  • Genetics of diabetes-associated microvascular complications, 2023, Diabetologia
  • Elevated circulating follistatin associates with an increased risk of type 2 diabetes, 2021, Nature Communications
  • Epigenetic markers associated with metformin response and intolerance in drug-naïve patients with type 2 diabetes, 2020, Science Translational Medicine
  • Lifestyle Intervention in Pregnant Women With Obesity Impacts Cord Blood DNA Methylation, Which Associates With Body Composition in the Offspring, 2021, Diabetes

Vaag frequently collaborates with a number of co-authors including Torben Hansen, Charlotte Brøns, Jens Steen Nielsen, Reimar W. Thomsen, and Henrik Toft Sørensen, indicating a network of professional partnerships focused on diabetes and related metabolic disorders.

Best Publications

  • Epigenetic differences arise during the lifetime of monozygotic twins

    Mario F. Fraga;Esteban Ballestar;Maria F. Paz;Santiago Ropero

  • Interleukin-1-receptor antagonist in type 2 diabetes mellitus.

    Claus M Larsen;Mirjam Faulenbach;Allan Vaag;Allan Vaag;Aage Vølund

  • Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

    D. Russell-Jones;A. Vaag;O. Schmitz;B. K. Sethi

  • Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance--a population-based twin study.

    P. Poulsen;K.O. Kyvik;A. Vaag;H. Beck-Nielsen

  • Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk: A Population Study of 3.3 Million People

    Tina Ken Schramm;Gunnar H. Gislason;Lars Køber;Søren Rasmussen

  • Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors

    Nicole M Warrington;Robin N Beaumont;Momoko Horikoshi;Felix R Day

  • Genome-wide associations for birth weight and correlations with adult disease

    Momoko Horikoshi;Robin N. Beaumont;Felix R. Day;Nicole M. Warrington;Nicole M. Warrington

  • Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia.

    Johan Rung;Stéphane Cauchi;Anders Albrechtsen;Lishuang Shen;Lishuang Shen

  • TXNIP regulates peripheral glucose metabolism in humans

    Hemang Parikh;Emma Carlsson;Emma Carlsson;William A Chutkow;Lovisa E Johansson

  • Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study.

    Tina Ken Schramm;Gunnar Hilmar Gislason;Allan Vaag;Jeppe Nørgaard Rasmussen

  • Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients.

    M. A. Gall;P. Rossing;P. Skøtt;P. Damsbo

  • Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

    Bianca Hemmingsen;Søren S Lund;Christian Gluud;Allan Vaag

  • Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

    Bianca Hemmingsen;Søren S Lund;Christian Gluud;Allan Vaag

  • Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes

    Claus M. Larsen;Mirjam Faulenbach;Allan Vaag;Jan A. Ehses

  • Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus.

    Allan Vaag;Jan Erik Henriksen;Henning Beck-Nielsen

  • Low birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs

    P. Poulsen;A. A. Vaag;K. O. Kyvik;D. Møller Jensen

  • Altered DNA methylation and differential expression of genes influencing metabolism and inflammation in adipose tissue from subjects with type 2 diabetes.

    Emma Nilsson;Per Anders Jansson;Alexander Perfilyev;Petr Volkov

  • Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins.

    Charlotte Ling;Pernille Poulsen;Emma Carlsson;Martin Ridderstråle

  • Low birthweight is associated with specific changes in muscle insulin-signalling protein expression

    S. E. Ozanne;C. B. Jensen;K. J. Tingey;H. Storgaard

  • Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes.

    Helena Dominguez;Heidi Storgaard;Christian Rask-Madsen;Thomas Steffen Hermann

Frequent Co-Authors

Oluf Pedersen
Oluf Pedersen University of Copenhagen
Henning Beck-Nielsen
Henning Beck-Nielsen Odense University Hospital
Leif Groop
Leif Groop Lund University
Torben Hansen
Torben Hansen University of Copenhagen
Sten Madsbad
Sten Madsbad University of Copenhagen
Sjurdur F. Olsen
Sjurdur F. Olsen Statens Serum Institut
Lars Køber
Lars Køber Copenhagen University Hospital
Christian Torp-Pedersen
Christian Torp-Pedersen Aalborg University
Jørgen F. P. Wojtaszewski
Jørgen F. P. Wojtaszewski University of Copenhagen
Lise Tarnow
Lise Tarnow Steno Diabetes Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn’t always mean following the traditional road to becoming a doctor. Today, there are numerous best online bsn to dnp programs that allow registered nurses to advance their qualifications and clinical expertise from anywhere, offering greater flexibility for working professionals.

For those interested in pharmacy, accredited online pharmacy programs are available, enabling learners to earn advanced credentials while balancing job and family life. Another emerging field is health information management, where you can earn an online mhi (Master of Health Informatics) to build essential skills in managing patient data and health technology.

If you’re eager to enter the healthcare sector quickly, consider earning a billing and coding certificate. Take the time to research medical billing and coding certification cost to find affordable and reputable training options. Each of these pathways offers a promising career in healthcare, whether you prefer clinical, administrative, or technology-driven roles.

Best Scientists Citing Allan Vaag

Trending Scientists

Recently Published Articles